Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
34,150 KRW +3.96% Intraday chart for Hanall Biopharma Co., Ltd. +8.24% -22.91%
14/05 Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03/05 HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
HANALL BIOPHARMA CO., LTD.
Other Pharmaceuticals
+3.96%+8.24%-22.91%+52.80%+24.18% 1.26B
Bearish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Charts Hanall Biopharma Co., Ltd.
  5. Comparison Chart